INTEGRATE IIa: A randomised, double-blind, phase III study of regorafenib versus placebo in refractory advanced gastro-oesophageal cancer (AGOC)—A study led by the Australasian Gastro-intestinal Trials Group (AGITG).
| Autor: | Pavlakis, Nick, Shitara, Kohei, Sjoquist, Katrin Marie, Martin, Andrew James, Jaworski, Anthony, Yip, Sonia, Bang, Yung-Jue, Alcindor, Thierry, O'Callaghan, Christopher J., Tebbutt, Niall C., Strickland, Andrew, Rha, Sun Young, Lee, Keun-Wook, Zalcberg, John Raymond, Price, Timothy Jay, Simes, John, Goldstein, David |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2/1/2023 Supplement 1, Vol. 41, pLBA294-LBA294, 1p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|